脊椎管狭窄症治療のグローバル臨床試験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Spinal Stenosis Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Spinal Stenosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Spinal Stenosis to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Spinal Stenosis to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Spinal Stenosis 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Spinal Stenosis Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Sucampo Pharmaceuticals, Inc. 31
Clinical Trial Overview of Sucampo Pharmaceuticals, Inc. 31
Mesoblast Limited 32
Clinical Trial Overview of Mesoblast Limited 32
Zimmer Holdings, Inc. 33
Clinical Trial Overview of Zimmer Holdings, Inc. 33
United Therapeutics Corporation 34
Clinical Trial Overview of United Therapeutics Corporation 34
Nissan Chemical Industries, Ltd. 35
Clinical Trial Overview of Nissan Chemical Industries, Ltd. 35
LTT Bio-Pharma Co., Ltd. 36
Clinical Trial Overview of LTT Bio-Pharma Co., Ltd. 36
KT&G Corporation 37
Clinical Trial Overview of KT&G Corporation 37
Kaken Pharmaceutical Co., Ltd. 38
Clinical Trial Overview of Kaken Pharmaceutical Co., Ltd. 38
Biomet, Inc. 39
Clinical Trial Overview of Biomet, Inc. 39
Clinical Trial Overview of Top Institutes / Government 40
Seoul National University Hospital 40
Clinical Trial Overview of Seoul National University Hospital 40
Keio University 41
Clinical Trial Overview of Keio University 41
Hamamatsu University School of Medicine 42
Clinical Trial Overview of Hamamatsu University School of Medicine 42
University of Pittsburgh 43
Clinical Trial Overview of University of Pittsburgh 43
Vanderbilt University 44
Clinical Trial Overview of Vanderbilt University 44
Leiden University Medical Center 45
Clinical Trial Overview of Leiden University Medical Center 45
Yonsei University 46
Clinical Trial Overview of Yonsei University 46
Dartmouth-Hitchcock Medical Center 47
Clinical Trial Overview of Dartmouth-Hitchcock Medical Center 47
Emory University 48
Clinical Trial Overview of Emory University 48
Federal University of Sao Paulo 49
Clinical Trial Overview of Federal University of Sao Paulo 49
Five Key Clinical Profiles 50
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 70


【レポート販売概要】

■ タイトル:脊椎管狭窄症治療のグローバル臨床試験動向(2014年下半期)
■ 英文:Spinal Stenosis Global Clinical Trials Review, H2, 2014
■ 発行日:2014年7月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC2284CTIDB
■ 調査対象地域:グローバル
  • オンボードネット接続:衛星とLTEの競争
    n/a
  • 骨髄異形成症候群(MDS)治療薬の世界市場2015-2019
    About Myelodysplastic Syndrome Myelodysplastic syndrome is a group of hematologic disorders that arise in the bone marrow and spread into the blood. The syndrome is characterized by the inability of the hematopoietic cells produced in the bone marrow to attain maturity. Cytological dysplasia is a common feature of the syndrome, progressing to acute myeloid leukemia in about 30% of individuals with …
  • Delirium:グローバル臨床試験レビューH1, 2013
    Delirium Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Delirium Global Clinical Trials Review, H1, 2013" provides data on the Delirium clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Delirium. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
  • ガソリン直噴エンジン(GDI)システムの世界市場
    An automotive gasoline direct injection system injects fuel (diesel or gasoline) into the combustion chamber of an engine. The main components of an automotive gasoline direct injection system are the fuel pump, fuel injectors, fuel pressure regulators, and sensors. The gasoline direct injection technology begun from the need to improve the thermodynamic efficiency (reducing fuel consumption) and …
  • デリバティブの世界市場2015-2019
    Covering: Market forecast and growth drivers for the global derivatives market until 2019. Market segmentation by exchange traded derivatives, semi-annual OTC derivatives, and triennial OTC derivatives. The market shares for North America, APAC, and Europe are also provided in this report. The report includes an analysis of the leading market vendors such as ANZ, BNP Paribas, Deutsche Bank, Goldma …
  • ヘルスケアSCMの世界市場2016-2020
    Technavio’s research analyst predicts the global healthcare SCM market to grow steadily at a CAGR of 10% over the next four years. The need to improve traceability in the healthcare SCM system is the primary growth driver for this market. Healthcare SCM helps organizations with labor optimization, financial management, and smooth flow of information throughout the entire supply chain. Over the yea …
  • ヘキサンの世界市場分析:グレード別(重合、抽出)、用途別(食用油抽出、工業用溶剤、接着剤配合、皮革処理)、動向分析
    The global hexane market is expected to reach USD 2.36 billion by 2024, according to a new report by Grand View Research, Inc. The growth of oil extraction industry is expected to remain a key factor driving the global hexane market over the forecast period. Growing use of hexane across key end-use industries such as rubber and petrochemical is anticipated to boost the global market over the next …
  • ローグレード星状細胞腫:世界の臨床試験レビュー(2014年上半期)
    Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014" provides data on the Low-Grade Astrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Low-Grade Astrocytoma. It includes an overview of the trial numbers and the …
  • 製品情報管理(PIM)の世界市場:ソフトウェア、サービス、導入、ユーザー、産業、地域別分析
    MarketsandMarkets forecast the Product Information Management (PIM) market size to grow from USD 5.11 Billion in 2016 to USD 15.78 Billion by 2021 with a CAGR of 25.3%. Indispensable requirement to have centrally managed data and rising need for compliance and verification are the main drivers of the Product Information Management market. Presently, on-premise based deployment of PIM has the large …
  • シンフィルム(Thin-Film)印刷電池市場2014-2021
    NanoMarkets has provided coverage on the thin-film and printed batteries market for six years and has a deep understanding of what makes this market tick. During the period we have covered these power sources, some of the firms in this space have made slow but steady progress both technically and in terms of business development; a few of them are generating significant revenue. Other thin-film an …
  • EOR年報2016:増進回収法(EOR)完全ガイドブック
    • Do you need one definitive document that provides a comprehensive outlook for all aspects of enhanced oil recovery? • Do you need to know how the current oil price impacts EOR prospects? • Are you looking to find out which EOR technology is most likely to prevail: Gas, Chemical or Thermal EOR technologies? • Do you need revealing company market share data of the leading players for each EOR tech …
  • 不正検知・不正防止ソリューションの世界市場予測(~2021年)
    The Fraud Detection and Prevention Market size is expected to grow from USD 14.36 Billion in 2016 to USD 33.19 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 18.2% during the forecast period. The major growth drivers of the FDP market include the rise in online businesses and electronic transactions, rapid increase in mobile banking, and emergence of big data analytics. The Fraud Dete …
  • 二酸化炭素(CO2)石油増進回収(EOR)の世界市場2016-2026
    The latest report from business intelligence provider visiongain offers in depth analysis of the global carbon dioxide (CO2) enhanced oil recovery (EOR) market. Visiongain estimates CAPEX, including investments on anthropogenic carbon capture facilities and equipment for CO2 EOR at $3.78bn in 2016. The three biggest CO2 EOR markets in terms of CAPEX, the US, Canada and China, are set to grow at le …
  • エンタープライズ製造インテリジェンス(EMI)の世界市場2017-2021
    About Enterprise Manufacturing IntelligenceEnterprise manufacturing intelligence (EMI) is defined as a software that brings an organization's real-time manufacturing-related data together and performs functions such as aggregating, contextualizing, analyzing, visualizing, and propagating the data to form a visual summary. Technavio’s analysts forecast the global enterprise manufacturing intelligen …
  • 無機シンチレータのグローバル市場動向(~2018)
    The global inorganic scintillators market is segmented on the basis of type, applications, and geography. Based on type the global inorganic scintillators market includes CsI, NaI, GoS, and others. Based on applications the global inorganic scintillators market is broadly categorized into healthcare, nuclear power plants, industrial, and homeland security and defense. In 2013, the healthcare accou …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。